Cardiac effects 2 years after successful non-myeloablative human leukocyte antigen-matched related donor hematopoietic cell transplants in sickle cell disease

Am J Hematol. 2023 Aug;98(8):E219-E221. doi: 10.1002/ajh.26985. Epub 2023 Jun 7.

Authors

Affiliations

¹ NHLBI, National Institutes of Health, Bethesda, Maryland, USA.
² University of Illinois at Chicago, Chicago, Illinois, USA.
³ King Abdulaziz Medical City, Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia.
⁴ King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
⁵ King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural

MeSH terms

Anemia, Sickle Cell* / therapy
Graft vs Host Disease*
HLA Antigens
Hematopoietic Stem Cell Transplantation*
Humans
Tissue Donors
Transplantation Conditioning

Substances

HLA Antigens

Grants and funding